FINWIRES · TerminalLIVE
FINWIRES

Malaysian Blue-Chip Index Ends in Green Bucking Regional Jitters

By

Malaysian shares closed slightly higher on Monday, with the FTSE Bursa Malaysia KLCI up 0.7% at 1,698.01 points, against the downbeat performance of regional peers amid escalating oil prices.

In local news, Malaysia's Petronas Carigali and Thailand's PTT (SET:PTT) have obtained government approvals for a new production-sharing contract which covers a major gas block in the Malaysia-Thailand Joint Development Area. The contract for Block A-18-01 was signed in Bangkok by the state energy company's stepdown subsidiary, PC JDA, which is a direct subsidiary of Petronas Carigali.

In corporate news, shares of Kelington (KLSE:KGB) gained about 2% on close after its subsidiary, Kelington Engineering (S), accepted a letter of award worth around $452 million for turnkey total facility tool-hookup services at a semiconductor plant in India.

Shares of Kluang Rubber Co. (Malaya) (KLSE:KLUANG) also gained about 2% on Monday's close after it recorded a fresh fruit bunch crop production of 975.88 metric tonnes in August.

Sungei Bagan Rubber Company (Malaya)'s (KLSE:SBAGAN) fresh fruit bunch production totaled 2,388.1 metric tonnes in August.

What else is happening in Asia?

Asia

Orora Chief Safety, Sustainability, Governance Officer to Step Down at End of Year

Orora (ASX:ORA) said Ann Stubbings plans to step down as chief safety, sustainability, and governance officer, effective Dec. 31, after more than 13 years with the packaging products firm, according to a Monday filing with the Australian bourse.In addition, Susannah Jobling Hodgens will be appointed as chief legal officer, the company said. Hodgens has worked with Orora for 13 years in senior legal and governance roles, most recently as general counsel and alternate company secretary.Orora shares gained nearly 1% in recent Monday trade.

ASX:ORA
Asia

Biokin Pharma Enrolls First Patient in Phase Three Trial for Breast Cancer Drug; Shares Up 4%

Sichuan Biokin Pharmaceutical (SHA:688506) enrolled the first subject for the third-phase clinical trial of biologic drug T-Bren for injection, according to a weekend filing with the Shanghai bourse.The trial evaluates T-Bren combined with pertuzumab versus standard chemotherapy in neoadjuvant treatment of HER2-positive breast cancer, according to a weekend filing with the Shanghai bourse.Shares of the pharmaceutical company rose 4% in recent trade.

SHA:688506
Asia

Market Chatter: Korea Exchange to Extend Trading Hours till 8PM

South Korea's main stock market, the Korea Exchange, will enable trading till 8 pm following the regular close at 3:30 pm from Monday, in its move toward 24-hour trading, Bloomberg News reported Sunday.This decision opens 2,400 Korea Composite Stock Price Index, or Kospi, and Kosdaq stocks for evening trades, which include short-selling. The move excludes exchange-traded funds, the report said.The Korea Exchange plans to introduce pre-market trading by the end of next year, it said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

^KOSDAQKOSPI